valoctocogene roxaparvovec
270-301
Phase 3 mab active
Quick answer
valoctocogene roxaparvovec for Hemophilia A is a Phase 3 program (mab) at BioMarin International Limited with 5 ClinicalTrials.gov record(s).
Program details
- Company
- BioMarin International Limited
- Indication
- Hemophilia A
- Phase
- Phase 3
- Modality
- mab
- Status
- active